Regional Transformation Begins with Local Healthcare Champions: HIMSS Asia Pacific

Food and Healthcare Press Releases Monday July 4, 2016 16:50
SINGAPORE--4 Jul--PRNewswire/InfoQuest

Bangkok Hospital has achieved HIMSS Analytics EMRAM Stage 6, becoming the second hospital in Thailand to reach this high level of HIT adoption and usage. Their achievement follows closely after Paknampo Hospital became the first in Thailand to achieve Stage 6 in March.

Thailand's Healthcare Information Technology (HIT) development has been heterogeneous at best, with the private sector leading the way. Even so, major hospital groups continue to face challenges when implementing cross-departmental and group-wide solutions due to political, cost and strategic planning factors. Bigger groups are also fragmented in terms of leadership and operational objectives, making it harder for coordination and agreement on preferred solution providers and best solutions.

A silver lining does exist, and continued growth of the HIT market in Thailand points to a critical factor – local champions. Said Simon Lin, Executive Director, HIMSS Asia Pacific: "Over the past 18 months, HIMSS has engaged with several major healthcare organizations and what we found is that while there remains many challenges, people are still the key drivers behind such projects, and in Thailand for example, there are local HIT champions who are constantly pushing the envelope and driving innovation and HIT uptake. In fact, we are witnessing these people who share the same mission as HIMSS shape the very future of Thailand's healthcare."

Dr. Somsak Wankijcharoen, CIO of Bangkok Hospital and the main driver behind its EMRAM Stage 6 achievement is one such local HIT champion. "We aim to transform healthcare by becoming a leading data-driven hospital.   HIMSS Analytics EMRAM gave us a roadmap to achieve this goal.   This is the approach to facilitate our world standard clinical services," said Dr. Wankijcharoen, who is also a head and neck cancer specialist and a self-taught HIT enthusiast who has, in his personal and professional capacities, advocated for the use of HIT since the mid-90s.

Dr. Narinthorn Surasinthorn, Assistant Hospital Director at Samitivej Sukhumvit Hospital and social media ambassador for HIMSS AsiaPac16 also demonstrates how clinicians can leverage on social media tools to educate. Affectionately known as Dr. Carebear by patients in Thailand, he offers wellness advice on social media platforms to a network of over 400,000 followers. "At Samitivej, we are dedicated to continuously improve our service quality and outreach. To be able to contribute as a social media enthusiast and clinician has proved to be extremely beneficial to our patients and to the hospital," said Dr. Narinthorn.

In New Zealand, HIMSS has recently signed its first Association Affiliate agreement with Health Informatics New Zealand (HiNZ), signaling a new chapter in HIT engagement there. Kim Mundall, Chief Executive, HiNZ said, "New Zealand has a fast growing and vibrant digital health community. We see the collaboration between HiNZ and HIMSS as a key step to building stronger networks between our members and the international experts in digital health."

Regional transformation takes time but with recent engagement activities such as regional roadshows, the upcoming launch of HIMSS Asia Pacific communities, as well as HIMSS AsiaPac16 in Bangkok this August, HIMSS Asia Pacific will continue to encourage HIT champions, adopters and conversations for the betterment of care in the years to come.

Hospital tours to Bangkok Hospital, Samitivej Sukhumvit, and Bumrungrad International are available only at HIMSS AsiaPac16 . Early bird ends 22 July.

Latest Press Release

Open nursing course to accelerate the safe practice of Peripheral Intravenous Cannula Insertion

"Peripheral Intravenous Cannula Insertion is a very broad term and not likely to be understood by people outside the medical community. In simple terms, it means the provision of saline, medication or blood products through an intravenous device and...

Sirtex Medical reaches milestone 100,000th patient dose delivery of SIR-Spheres(R) Y-90 resin microspheres

- Physicians and employees recognized for their role in this milestone and impact made on patient lives Sirtex Medical, a leading manufacturer of targeted liver cancer therapies, today announced delivery of the 100,000th patient dose of SIR-Spheres(R)...

Most Thai consumers want to improve their diets and are open to healthier product reformulation

According to a new report by Food Industry Asia (FIA) and research firm IGD, almost all consumers in Thailand (99 per cent) are interested in improving their diets and a majority (82 per cent) are happy for products to be reformulated, provided that...

Kemin Launches New Vision and Logo for the Future

Global ingredient manufacturer sets sights on sustainably transforming 80 percent of the world by 2042 Today Kemin Industries, a global ingredient manufacturer, unveiled its new global vision and logo to align the company strategically for 2042 and...

Oral semaglutide demonstrated cardiovascular safety in people with type 2 diabetes and established cardiovascular disease or high cardiovascular risk in PIONEER 6 trial

Novo Nordisk today announced that the PIONEER 6 trial achieved its primary endpoint by demonstrating non-inferiority of major adverse cardiovascular events (MACE) with oral semaglutide compared with placebo, both in addition to standard of care. The...

Related Topics